Published Online: June 25, 2015. doi:10.1001/jamaophthalmol.2015.1946.
Study concept and design: Baumal, de Carlo, Waheed, Witkin, Duker.
Acquisition, analysis, or interpretation of data: de Carlo, Salz, Witkin.
Drafting of the manuscript: Baumal, Witkin.
Critical revision of the manuscript for important intellectual content: de Carlo, Waheed, Salz, Witkin, Duker.
Administrative, technical, or material support: Salz, Witkin, Duker.
Study supervision: Baumal, Waheed, Salz, Witkin, Duker.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Baumal reported serving as a consultant for Allergan and receiving a travel grant from Optovue. Dr Waheed reported serving as a consultant for Iconic Therapeutics; serving on the speakers bureau for Thrombogenics; and receiving research support from Carl Zeiss Meditec. Dr Duker reported serving as a consultant for and receiving research support from Carl Zeiss Meditec and Optovue. No other disclosures were reported.
Funding/Support: This work was supported in part by an unrestricted grant to the New England Eye Center, Tufts University School of Medicine from Research to Prevent Blindness and by the Massachusetts Lions Club.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Previous Presentation: This article was presented in part at the Atlantic Coast Retina Club 2015 Meeting; January 9, 2015; Boston, Massachusetts.